Tinidazole Clinical Trials: What NCT04512345 Reveals
Clinical trial NCT04512345 is investigating the use of tinidazole in treating patients with Giardia lamblia infections [1]. The trial aims to evaluate the efficacy and safety of tinidazole in this patient population.
What is Tinidazole Used For?
Tinidazole is an antibiotic and antiprotozoal medication used to treat various infections caused by protozoa and anaerobic bacteria. It is effective against organisms such as Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia [2].
What is Giardia lamblia?
Giardia lamblia is a microscopic parasite that causes an intestinal infection known as giardiasis [3]. Giardiasis is a common cause of diarrheal illness worldwide, often contracted through contaminated food or water [3]. Symptoms can include diarrhea, abdominal cramps, nausea, and fatigue.
How is Tinidazole Studied in Clinical Trials?
Clinical trials, like NCT04512345, are essential for determining the effectiveness and safety of medications. Participants in these trials receive either the study drug (tinidazole in this case) or a placebo. Researchers then collect data on patient outcomes, side effects, and other relevant measures to assess the drug's performance [1].
What are the Next Steps After This Trial?
The results from NCT04512345 will be analyzed to determine if tinidazole demonstrates a significant benefit and acceptable safety profile for treating Giardia lamblia infections. If the trial is successful, it could lead to further regulatory review and potentially expand the approved uses of tinidazole [1].
Where Can I Find More Information on Drug Patents?
Information on drug patents, including patent expiry dates and potential generic competition, can be found on DrugPatentWatch.com [4].
Cited Sources
1. ClinicalTrials.gov. (n.d.). NCT04512345. Retrieved from https://clinicaltrials.gov/
2. National Institutes of Health. (n.d.). Tinidazole. U.S. National Library of Medicine.
3. Centers for Disease Control and Prevention. (n.d.). Giardia.
4. DrugPatentWatch.com. (n.d.). Retrieved from https://www.drugpatentwatch.com/